
July 14, 2022
Development of peptide-based probes as imaging and targeting agents for glioblastoma therapy
Glioblastoma (GBM), the most aggressive primary brain tumors in adults, is feared for its near uniformly fatal prognosis. Due to its infiltrative nature, surgery alone is ineffective in disease eradication. We originally identified abnormal cancer stem cells called brain tumor-initiating cells (BTICs) that lead to the formation of this brain tumor. These BTICs are known […]
Read More